Senior Scientist I

Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), a global, research-based biopharmaceutical company. Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products and a pipeline containing multiple promising new molecules that are being studied in more than 200 clinical trials for over 20 different types of cancer.

More than 1,200 Pharmacyclics and AbbVie research scientists, clinicians, marketing, operations and corporate professionals work in the San Francisco Bay Area. They combine their expertise in immuno-oncology, stem cells, and cell-signaling with their knowledge of bispecific antibodies, antibody-drug conjugates (ADCs), and covalent-inhibitor technologies to discover and develop novel cancer treatments. Together, we are striving to outsmart cancer.

Provide strong scientific and technical initiative and hands-on implementation of assay development and new target identification/validation in the fields of hematologic malignancies and immuno-oncology. Conceive and execute novel scientific approaches to achieve departmental project goals.
Key Accountabilities/Core Job Responsibilities

Devise and implement strategies to identify new targets in hematological malignancies and immune-oncology.
Actively participate in internal and external scientific meetings by presenting and critically evaluating emerging scientific literature to contribute to projects.
Impact projects through experimental designs, critical analysis and interpretation of results and communication of results promptly
Read and evaluate scientific literature
Strong relationships with peers and cross functionally with partners to achieve high performance. Strongly embrace the ideas of others and nurtures innovations.